"10.1371_journal.pone.0055038","plos one","2013-01-28T00:00:00Z","Jan Vesterbacka; Piotr Nowak; Babilonia Barqasho; Samir Abdurahman; Jessica Nyström; Staffan Nilsson; Hiroyuki Funaoka; Tatsuo Kanda; Lars-Magnus Andersson; Magnus Gisslèn; Anders Sönnerborg","Unit of Infectious Diseases, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Department of Laboratory Medicine, Division of Clinical Microbiology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Department of Mathematical Statistics, Chalmers University of Technology, Gothenburg, Sweden; DS Pharma Biomedical Company, Limited, Osaka, Japan; Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan; Department of Infectious Diseases, University of Gothenburg, Gothenburg, Sweden","Conceived and designed the experiments: JV, PN, AS, HF, TK, L-MA, MG. Performed the experiments:. BB, SA, JN. Analyzed the data: JV, PN, AS. Wrote the paper: JV, PN, AS.","The authors do not have a commercial or other association that might pose a conflict of interest with the exception of Dr HF is employed by DS Pharma Biomedical Co., Ltd, the company that developed a kit for I-FABP. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Jan Vesterbacka","JV",11,TRUE,7,NA,3,3,FALSE,FALSE,TRUE,9,"1;2;3;4;5;6;7;8;9",TRUE
